The effect of Ezetimibe or pyridoxine in Patients with Primary Biliary Cirrhosis.
- Registry ID
- EUCTR2006-006742-34
- Source registry
- EUCTR
- Status
- Prematurely Ended
- Phase
- PHASE4
- Sponsor
- Barts and The London NHS Trust
- Start date
- 2007-06-28
- Completion date
- 2013-03-08
- Last update
- 2026-08-16
Conditions
- primary biliary cirrhosis
Summary
The effect of ezetimibe on cholesterol levels. Previous studies have shown that ezetimibe 10mg reduces cholesterol levels by 18%.
Locations
View on source registry